Top compounds associated with response to PRR20B


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.2
mRNA BMS-195614 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA sitagliptin CTRPv2 pan-cancer AAC -0.082 0.2
mRNA BEC CTRPv2 pan-cancer AAC -0.082 0.2
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC -0.04 0.2
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA myriocin CTRPv2 pan-cancer AAC -0.086 0.3
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC 0.045 0.3
Download CSV